Krka's Q3 Group Profit Lower Despite Higher Sales
Novo Mesto, 15 November - The group around pharma company Krka posted a net profit of EUR 111.5m for the first three quarters of the year, down 3% over the same period in 2011, as operating profit (EBIT) dropped 15% to EUR 143.4m on the back of revenue that was up 6% to EUR 813.9m.
Novo mesto
Krka CEO Jože Colarič presents the company's January-September results.
Photo: Rasto Božič/STA
Novo mesto
Krka CEO Jože Colarič presents the company's January-September results.
Photo: Rasto Božič/STA
Novo mesto
Krka CEO Jože Colarič presents the company's January-September results.
Photo: Rasto Božič/STA
Novo mesto
Krka chairman Jože Colarič surrounded by reporters at a news conference dedicated to the pharmaceutical company's nine-month operating results.
Photo: Rasto Božič
The rest of this news item is available to subscribers.
The news item consists of 855 characters (without spaces) or 180 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.